Literature DB >> 6167117

A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.

B Statham, A Y Finlay, R Marks.   

Abstract

Fourteen patients with a clinical and histological diagnosis of necrobiosis lipoidica were treated in a double-blind control study with either an aspirin dipyridamole combination or a matching placebo for an 8-week period. None of the patients in the aspirin dipyridamole group showed a significant improvement.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6167117

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  The skin in diabetes mellitus.

Authors:  M J Goodfield; L G Millard
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  Necrobiosis lipoidica diabeticorum: response to pentoxiphylline.

Authors:  S Basaria; M Braga-Basaria
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

3.  Aspirin in dermatology: Revisited.

Authors:  Aditya Kumar Bubna
Journal:  Indian Dermatol Online J       Date:  2015 Nov-Dec

4.  Necrobiosis lipoidica diabeticorum: A case-based review of literature.

Authors:  Sunil Kumar Kota; Sruti Jammula; Siva Krishna Kota; Lalit Kumar Meher; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-07

Review 5.  Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.

Authors:  Amir Feily; Shadi Mehraban
Journal:  Dermatol Reports       Date:  2015-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.